Drug
Cyproterone
Cyproterone: highest development phase Phase 3, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cyproterone acetate NCT01011751 | Phase 3 | Adenocarcinoma, Prostate |
Latest
No recent events.
Follow Cyproterone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.